亚洲国产一-亚洲国产系列一区二区三区-亚洲国产系列久久精品99人人-亚洲国产午夜精品乱码-国产在线精品99一卡2卡-国产在线黄色

索拉非尼

 
 
單價 2.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 1000000000KG起訂1KG
品牌 康寶泰
過期 長期有效
更新 2014-10-17 14:45
 

湖北康寶泰精細化工有限公司原料銷售部

企業會員第14年
資料未認證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2014-10-22
  • 陳小玲 (女士)   銷售經理
詳細說明

聯系人:陳小姐  電話:027-87738653

索拉非尼
CAS號: 284461-73-0
中文同義詞: 索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;對***磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼堿;索拉替尼
英文名稱: Sorafenib tosylate
英文同義詞: sorafenib;SORAFENIB-D3;SORAFENIB TOLSYLATE;RAF1 KINASE INHIBITOR II;N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-((4-(2-(N-METHYL-CARBAMOYL)(4-PYRIDYLOXY))PHENYL)AMINO)CARBOXAMIDE;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide;BAY 43-9006;SORAFENIB MESYLATE
分子式: C21H16ClF3N4O3
分子量: 464.83
標準:企標含量;99%
用途:抗腫瘤藥
包裝:根據客戶要求包裝 


產品技術與銷售咨詢熱線:027-87738653  QQ:418251814
產品技術與銷售咨詢熱線:027-87738653  QQ:418251814
產品技術與銷售咨詢熱線:027-87738653  QQ:418251814

以上產品是原料藥,只適宜科研研究實驗,客戶對其購買的產品使用和再加工或再銷售負法律和試用風險全責!

舉報收藏 0評論 0
更多>本企業其它產品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |